{'fraction_non_alphanumeric': 0.022330774598743892, 'fraction_numerical': 0.0027913468248429866, 'mean_word_length': 5.5479452054794525, 'pattern_counts': {'":': 0, '<': 0, '<?xml version=': 0, '>': 0, 'https://': 0, 'lorem ipsum': 0, 'www.': 0, 'xml': 0}, 'pii_count': 0, 'substrings_counts': 0, 'word_list_counts': {'cursed_substrings.json': 0, 'profanity_word_list.json': 0, 'sexual_word_list.json': 0, 'zh_pornsignals.json': 0}}
Pregnancy in Takayasu’s arteritis with bilateral renal artery and abdominal aorta stents

The incidence of Takayasu disease is 2–3 ⁄ million persons ⁄ year with female:male ratio of 9:1. In childbearing age group of women, incidence is higher; hence, the management of pregnancies with this disease is of great importance to obstetricians. It is a chronic, granulomatous, vasculitis of medium to large arteries with fibrous thickening and obliteration of the same. Takayasu disease in pregnancy has good maternal and fetal outcome and the basic disease remains unaffected by the pregnant state. Nevertheless, during the course of the pregnancy, maternal complications such as sustained hypertension, superimposed pre-eclampsia, congestive heart failure and progression of renal involvement should be anticipated. Increased severity of the disease may be associated with an increased likelihood of low-birthweight babies. The lowest possible dose of corticosteroids to control the disease is recommended. Azathioprine should be considered in few cases that do not respond to corticosteriods. Nowadays, both vascular surgery and balloon angioplasty have been found to be successful in both aorta and its branches when symptoms of vascular insufficiency occur. In our patient with Takayasu’s arteritis, who had already undergone renal artery and abdominal aorta stenting, the antenatal, intranatal and postnatal periods were uneventful.